Department of Mining-Metallurgy Engineering and Materials Science, POLYMAT, Faculty of Engineering in Bilbao, University of the Basque Country (UPV/EHU), Plaza Torres Quevedo 1, 48013 Bilbao, Spain.
POLYMAT, Applied Chemistry Department, Faculty of Chemistry, University of the Basque Country UPV/EHU, Paseo Manuel de Lardizabal 3, 20018 Donostia-San Sebastian, Spain.
ACS Appl Mater Interfaces. 2021 Apr 28;13(16):18511-18524. doi: 10.1021/acsami.1c01450. Epub 2021 Apr 16.
Polymer capsules fabricated the layer-by-layer (LbL) approach have emerged as promising biomedical systems for the release of a wide variety of therapeutic agents, owing to their tunable and controllable structure and the possibility to include several functionalities in the polymeric membrane during the fabrication process. However, the limitation of the capsules with a single functionality to overcome the challenges involved in the treatment of complex pathologies denotes the need to develop multifunctional capsules capable of targeting several mediators and/or mechanisms. Oxidative stress is caused by the accumulation of reactive oxygen species [, hydrogen peroxide (HO), hydroxyl radicals (OH), and superoxide anion radicals (O)] in the cellular microenvironment and is a key modulator in the pathology of a broad range of inflammatory diseases. The disease microenvironment is also characterized by the presence of proinflammatory cytokines, increased levels of matrix metalloproteinases, and acidic pH, all of which could be exploited to trigger the release of therapeutic agents. In the present work, multifunctional capsules were fabricated the LbL approach. Capsules were loaded with an antioxidant enzyme (catalase) and functionalized with a model drug (doxorubicin), which was conjugated to an amine-containing dendritic polyglycerol through a pH-responsive linker. These capsules efficiently scavenge HO from solution, protecting cells from oxidative stress, and release the model drug in acidic microenvironments. Accordingly, in this work, a polymeric microplatform is presented as an unexplored combinatorial approach applicable for multiple targets of inflammatory diseases, in order to perform controlled spatiotemporal enzymatic reactions and drug release in response to biologically relevant stimuli.
通过层层(LbL)方法制备的聚合物胶囊作为有前途的生物医学系统,已经用于释放各种治疗剂,这归因于其可调且可控的结构,以及在制造过程中有可能在聚合物膜中包含几种功能。然而,具有单一功能的胶囊的局限性在于难以克服治疗复杂病理的挑战,这就需要开发能够靶向几种介质和/或机制的多功能胶囊。氧化应激是由细胞微环境中活性氧物质([,过氧化氢(HO),羟基自由基(OH)和超氧阴离子自由基(O))的积累引起的,是广泛炎症性疾病病理的关键调节剂。疾病微环境的特征还包括促炎细胞因子的存在、基质金属蛋白酶水平升高和酸性 pH 值,所有这些都可以被利用来触发治疗剂的释放。在本工作中,通过层层(LbL)方法制备了多功能胶囊。将抗氧化酶(过氧化氢酶)装入胶囊中,并通过 pH 响应性连接子将模型药物(阿霉素)功能化到含有胺的树枝状聚甘油上。这些胶囊可有效地从溶液中清除 HO,保护细胞免受氧化应激,并在酸性微环境中释放模型药物。因此,在这项工作中,提出了一种聚合物微平台作为一种未被探索的组合方法,适用于炎症性疾病的多个靶点,以响应生物相关刺激进行受控的时空酶反应和药物释放。